Skip to main content

Alumis Inc.

ALMS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001847367

In the last 90 days, Alumis Inc. insiders filed 1 open-market purchase and 8 sales; 198 institutions reported holding it in 13F filings for Q2 2026, worth $3.32B in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Alumis Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of ALMS: Q3 2024 compared with Q4 2024
MeasureQ3 2024Q4 2024Change
Holders5264+12
Shares35.2M40.3M+5.05M (+14.3%)
Value$376.1M$316.5M−$59.6M (−15.9%)

New holders (15)

Institutions that held Alumis Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to ALMS in Q4 2024
InstitutionSharesValue% of portfolio
Foresite Capital Management VI LLC4,202,670$33.0M14.72%
Mariner, LLC18,122$142.4K0.00%
XTX Topco Ltd16,446$129.3K0.01%
Marshall Wace, LLP13,800$108.5K0.00%
China Universal Asset Management Co., Ltd.10,013$78.7K0.01%
Police & Firemen's Retirement System of New Jersey3,588$28.2K0.00%
Mirae Asset Global Investments Co., Ltd.1,574$12.7K0.00%
GF Fund Management Co. Ltd.992$7.80K0.00%
Nelson, Van Denburg & Campbell Wealth Management Group, LLC384$3.02K0.00%
EverSource Wealth Advisors, LLC182$1.43K0.00%
Massmutual Trust Co FSB144$1.13K0.00%
Daiwa Securities Group Inc.156$1.00K0.00%
CWM, LLC98$1.00K0.00%
Nisa Investment Advisors, LLC68$5340.00%
GAMMA Investing LLC19$1490.00%

Sold out (3)

Institutions that held Alumis Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of ALMS in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Maven Securities LTD50,000$534.0K
MetLife Investment Management8,303$88.7K
Catalyst Funds Management Pty Ltd300$3.20K